Baird Medical Investment Holdings (BDMD) Debt to Equity (2023 - 2025)

Baird Medical Investment Holdings' quarterly Debt to Equity came in at $0.28 in Q4 2025, up 157.06% year-on-year from $0.11 in Q4 2024, and up 157.06% quarter-over-quarter from $0.11 in Q4 2024.

Baird Medical Investment Holdings has reported Debt to Equity for 3 years, with the latest figure at $0.28 in Q4 2025.

  • For the quarter ending Q4 2025, Debt to Equity rose 157.06% year-over-year to $0.28; the trailing twelve-month figure through Dec 2025 stood at $0.28 (up 157.06% YoY), and the FY2025 full-year result was $0.28, up 157.06% from the prior year.
  • Debt to Equity for Q4 2025 stood at $0.28, up from $0.11 in the prior quarter.
  • The five-year high for Debt to Equity was $0.28 in Q4 2025, with the low at $0.07 in Q4 2023.
  • Average Debt to Equity over 3 years is $0.15, with a median of $0.11 recorded in 2024.
  • Year-over-year, Debt to Equity jumped 59.63% in 2024 and surged 157.06% in 2025.
  • Tracing BDMD's Debt to Equity over 3 years: stood at $0.07 in 2023, then soared by 59.63% to $0.11 in 2024, then surged by 157.06% to $0.28 in 2025.
  • The last three Debt to Equity figures came in at $0.28 (Q4 2025), $0.11 (Q4 2024), and $0.07 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.65
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.64
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.57
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.42
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.06
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.95
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.27
10 Baird Medical Investment Holdings - - - 0.28

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 0.28
Dec 31, 2024 0.11
Dec 31, 2023 0.07